Match Document Document Title
6323321 Antibody 97A6  
The present invention relates to a monoclonal antibody binding an antigen on the megakaryocytic cell line UT-7. The invention further relates to hybridoma cells producing such an antibody.
6316012 Cosmetic or pharmaceutical composition comprising, in combination, a peroxidase and an anti-singlet oxygen agent  
A method of preventing damage caused to healthy skin, hair or mucous membranes by free radicals, includes applying to the healthy skin, hair or mucous membrane a composition containing at least one...
6313268 Secretases related to Alzheimer's dementia  
This invention is directed to a novel β-secretase that produces the Aβ peptide found in Alzheimer's Disease. One β-secretase is a protein having a molecular weight of about 61, 81 or 88 kDa that...
6312687 Stabilized lactoperoxidase and glucose oxidase concentrate  
A stabilized aqueous enzyme concentrate composition which comprises: a) 1000 to 1800 units/ml of lactoperoxidase; b) 1500 to 2750 units/ml of glucose oxidase; c) 10 to 20% w/v of an alkali...
6312686 Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation  
Permeability of the blood-brain barrier and other physiological barriers can be modulated by the degree of tyrosine phosphorylation of proteins. Agents which promote tyrosine protein...
6303127 Treatment of disease states  
The invention presents methods for the treatment of symptoms associated with diseases states including cardiomyopathy, Parkinson's Disease and degenerative liver disease including cirrhosis...
6303119 Personal care compositions containing subtilisin enzymes bound to water insoluble substrates  
The present invention relates to personal care compositions comprising a water insoluble substrate, a plurality of Protease G enzymes, and a binding means, permanently attaching each of the enzymes...
6300098 Human signal transduction serine/threonine kinase  
An isolated and purified human Ste20-like serine/threonine signal transduction kinase is described. A cDNA sequence which encodes the native signal transduction molecule is disclosed as well as the...
6290951 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells  
A first substance (such as the peptide aldehydes LLnL and LVP) inhibits the function of intracellular proteasome. A second substance (such as ranpirnase) inhibits intracellular protein synthesis or...
6291533 Dietary supplements for each specific blood type  
Dietary supplement compositions designed to be responsive to specific blood types, and thus most beneficial for people with specific antigenic blood types.
6284246 Modified polypeptides with high activity and reduced allergenicity  
The present invention relates to a modified polypeptide which has an enzymatic activity level of greater than about 70% of the parent polypeptide and an allergenic response level of less than about...
6280725 Compositions and methods for inhibiting the growth of fungi  
A composition suitable for inhibiting the outgrowth of fungi is provided comprising a first ingredient which inhibits the biogenesis of a normal fungal cell wall and a second ingredient which is...
6280727 Compositions containing thrombin and microfibrillar collagen and methods for preparation and use thereof  
The present invention relates to thrombin-containing hemostatic compositions, their preparation and use. In particular, it relates to hemostatic compositions comprising stabilized thrombin and...
6277965 CysS  
The invention provides cysS polypeptides and DNA (RNA) encoding cysS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing cysS...
6277399 Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections  
A composition for treatment of bacterial infections of burns and wounds of the skin comprises an effective amount of at least one lytic enzyme produced by a bacteria infected with a bacteriophage...
6270762 tdk  
The invention provides tdk polypeptides polynucleotides encoding tdk polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing tdk...
6267956 Protein activator and apoptosis  
An isolated and purified human protein activator of apoptosis is described. A cDNA sequence which encodes the native kinase of death is disclosed as well as the structural coding region and the...
6268344 Methods for treating hypercoagulable states or acquired protein C deficiency  
A method of treatment for human patients with an acquired hypercoagulable state or acquired protein C deficiency associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and...
6264945 Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections  
The present invention discloses a method and composition for the treatment of bacterial infections by the parenteral introduction of at least one lytic enzyme produced by a bacteria infected with a...
RE37274 Method for nutritional oxygenation of the skin  
A skin treatment process designed to reduce the aging process of the skin and to cause the skin to become a semi-permeable membrane. The steps include exfoliation, cleansing, hydration, and...
6254866 Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract  
A method for treatment of bacterial infections of the digestive tract is disclosed which comprises administering a lytic enzyme specific for the infecting bacteria. The lytic enzyme is preferably...
6254869 Cryptopain vaccines, antibodies, proteins, peptides, DNA and RNA for prophylaxis, treatment and diagnosis and for detection of cryptosporidium species  
Vaccines, antibodies, proteins, DNAs and RNAs for diagnosis, prophylaxis, treatment and detection of Cryptosporidium species or Cryptosporidium species infections. Cryptosporidium species antigen...
6242175 Methods and means relating to retrotransposon and retroviral integration  
Ku(Ku70 and Ku80) of yeast and mammalian cells and other components of the Ku-associated DNA repair pathway are involved in retrotransposon and retroviral integration into cellular nucleic acids....
6242010 Synergistic antioxidant compositions in management of hemorrhoids and other ano-rectal inflammatory conditions  
Compositions for remediating ano-rectal inflammatory processes, hemorrhoidal syndromes and ano-rectal wounds. The composition includes the synergistic combination of reduced glutathione and...
6231853 Human glutathione peroxidase-6  
The invention provides a human glutathione peroxidase (GPx6) and polynucleotides which identify and encode GPx6. The invention also provides expression vectors, host cells, antibodies, agonists,...
6232292 3-dehydroquinate synthase  
The invention provides 3-DEHYDROQUINATE SYNTHASE polypeptides and DNA (RNA) encoding 3-DEHYDROQUINATE SYNTHASE polypeptides and methods for producing such polypeptides by recombinant techniques....
6228625 metK from Streptococcus pneumoniae  
The invention provides metK polypeptides and polynucleotides encoding metK polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for...
6228323 Multi-purpose compositions containing an alkyl-trypsin and methods of use in contact lens cleaning and disinfecting  
Two-compartment bottle assemblies useful in preparing multi-purpose compositions containing an Al-trypsin and disinfectant, methods of preparing these compositions and methods involving the use of...
6217862 TCTS response regulator  
Novel response regulator polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for...
6217861 Response regulator polypeptides of Streptococcus pheunoniae  
The invention provides Response Regulator and Histidine Kinase polypeptides and DNA (RNA) encoding such polypetides and methods for producing such polypeptides by recombinant techniques. Also...
6218350 Bleaching enzymes  
There is provided a bleaching enzyme capable of generating a bleaching chemical and having a high binding affinity for stains present on fabrics. Furthermore, there is provided an enzymatic...
6214338 Plasma concentrate and method of processing blood for same  
A plasma concentrate comprising one of platelets and platelet releasate and from 5 to 400 mg/ml of fibrinogen. The concentrate further includes a physiologically acceptable carrier comprising water...
6207148 Disease associated protein kinases  
The invention provides human disease associated protein kinases and polynucleotides (collectively designated DAPK) which identify and encode them. The invention also provides expression vectors,...
6207149 Starch binding domains (SBDs) for oral care products  
The present invention relates to an oral care composition comprising a Starch Binding Domain and further ingredients conventionally used in oral care compositions, oral care products, and the use...
6207729 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom  
Texturized cellulosic or lignocellulosic materials, and compositions and composites made therefrom, are disclosed.
6207200 Use of proteins as anti-retroviral agents  
The present invention relates to the discovery that a protein, having a molecular weight of about 14 Kd, extracted with perchloric acid from animal organs such as goat liver, has anti-retroviral...
6207151 Aqueous solution of t-PA  
Aqueous protein-containing solutions, in which a protein is dissolved at a high concentration at a pH near the isoelectric point of the protein by adding an anionic polymer or a salt thereof to the...
6200564 Pharmaceutical compositions containing chondroitinase and uses therefor  
Gastrointestinal mucus from patients suffering from cystic fibrosis has been found to contain large amounts of chondroitin sulfate polymer. This finding indicates that the enzyme chondroitinase is...
6190680 Oily composition and process for producing the same  
An oily composition comprises a solid phase containing a water-soluble effective substance and/or a water-dispersible effective substance and an oil phase containing an oily component and an...
6190894 Method and compositions for disrupting the epithelial barrier function  
A method for disrupting epithelial barrier function in a host in need of the topical administration of a physiologically active substance which comprises applying to the epithelium of the host,...
6177072 Soy hydrolysate and use in insect control  
Soy hydrolysate compositions are produced by a process utilizing multiple enzymes. The soy hydrolysate compositions provide insect attractant and repellent properties. Methods of using the soy...
6162786 Bacterial infection-preventive agent for fish and shellfish larvae, and method for breeding them  
A new effective bacterial infection-preventive agent for fish and shellfish larvae is provided. This agent contains a protease inhibitor such as ovomacroglobulin, α 2-macroglobulin or an analog...
6156523 Serine/threonine protein kinases  
The invention provides human serine/threonine protein kinases (HSTK) and polynucleotides which identify and encode HSTK. The invention also provides expression vectors, host cells, antibodies,...
6146624 Human ubiquitin-conjugating enzymes  
The invention provides a human ubiquitin-conjugating enzyme (HUBI) and polynucleotides which identify and encode HUBI. The invention also provides expression vectors, host cells, agonists,...
6146626 Defined enzyme mixtures for obtaining cells and treating wounds  
6139859 Methods and compositions for topical treatment of ectoparasites  
Methods and compositions for the topical treatment of ectoparasites on animal skin utilizing a water-soluble or water-dispersible, substantially air-impermeable liquid composition.
6139837 ATP-dependent RNA helicase protein  
The invention provides a human ATP-dependent RNA helicase (ADRH-1) and polynucleotides which identify and encode ADRH-1. The invention also provides expression vectors, host cells, agonists,...
6140475 Controlled dissolution crosslinked protein crystals  
Protein crystals crosslinked with a multifunctional crosslinking agent are produced that have the ability to change from an insoluble and stable form to a soluble and active form and to release...
6140063 In vitro screening assay for identification of compounds that inhibit cytopathicity of viral infection  
The present invention includes the method of treating a viral infection, specifically one occurring as a result of infection by a human immunodeficiency virus (HIV-1). The method of treatment...
6136606 Influenza vaccine compositions  
The invention provides a vaccine composition in the form of a kit, comprising a first container containing an antigenic preparation comprising influenza antigen or antigens; and a second container...